Sign in to view content

Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments

Rehan M. Hussain, MD

Video
Published 2021

Related

Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2018
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019
Subfoveal Choroidal Thickness as a Prognostic Factor in Exudative Age related Macular Degeneration.
Jaya B. Kumar, MD, FASRS
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more